KYTX - Kyverna Therapeutics, Common Stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KYTX is currently covered by 3 analysts with an average price target of $26.8. This is a potential upside of $17.93 (202.14%) from yesterday's end of day stock price of $8.87.

Kyverna Therapeutics, Common Stock's activity chart (see below) currently has 15 price targets and 16 ratings on display. The stock rating distribution of KYTX is 16.67% HOLD and 83.33% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 22.75 days.

Highest price target for KYTX is $33, Lowest price target is $5, average price target is $23.67.

Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 15-Dec-2025. First documented stock forecast 03-Mar-2024.

Best performing analysts who are covering KYTX - Kyverna Therapeutics, Common Stock:

Mitchell Kapoor Brian Cheng Derek Archila Michael Ulz

Currently out of the existing stock ratings of KYTX, 1 are a HOLD (16.67%), 5 are a BUY (83.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Oct-2025

$33

$24.13 (272.04%)

$31

3 months 20 days ago
(15-Dec-2025)

0/3 (0%)

$22.76 (222.27%)

Buy Since 03-Mar-2024

$33

$24.13 (272.04%)

$25

3 months 21 days ago
(14-Dec-2025)

0/4 (0%)

$22.18 (204.99%)

Hold Since 03-Jul-2024

$5

$-3.87 (-43.63%)

$4

10 months 9 days ago
(27-May-2025)

7/7 (100%)

$2.42 (93.80%)

91

Buy Since 03-Mar-2024

$33

$24.13 (272.04%)

$39

1 years 8 months 5 days ago
(31-Jul-2024)

0/2 (0%)

$24.34 (281.06%)

Show more analysts

Please expand the browser size to see the chart

What is KYTX (Kyverna Therapeutics, Common Stock) average time for price targets to be met?

On average it took 22.75 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on KYTX (Kyverna Therapeutics, Common Stock) with a proven track record?

MITCHELL KAPOOR

Which analyst has the current lower performing score on KYTX (Kyverna Therapeutics, Common Stock) with a proven track record?

MICHAEL ULZ

Which analyst has the most public recommendations on KYTX (Kyverna Therapeutics, Common Stock)?

Mitchell Kapoor works at HC WAINWRIGHT and has 9 price targets and 7 ratings on KYTX

Which analyst is the currently most bullish on KYTX (Kyverna Therapeutics, Common Stock)?

Michael Ulz with highest potential upside - $24.13

Which analyst is the currently most reserved on KYTX (Kyverna Therapeutics, Common Stock)?

Mitchell Kapoor with lowest potential downside - -$3.87

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?